ERBB2 and breast carcinoma: Therefore, we investigated the effects of ganetespib on cell proliferation/viability in BT474 and SKBR3 ErbB2+ breast cancer cell lines using an MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.